{
  "docId": "019de075-0704-766b-8dc2-5164487e52e7",
  "docSlug": "289762853c89269e6344134613f84a84",
  "documentTitle": "OmniAb | Investor Presentation Deck | 39 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 39,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 7,
  "notes": "The slide uses a combination of bulleted lists, a comparison table, and a bar chart to demonstrate market momentum.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-0704-766b-8dc2-5164487e52e7/5",
  "deckHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7",
  "deckJsonHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7.json",
  "deckAnchorHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.3,
        "x": 0.63,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Acceleration of Regulatory Approvals (FDA and EMA) showing growth from Pre-2000 to 2011-2020",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c963b35c-43d3-4d25-a4f9-139e300aa76d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.06,
        "y": 0.33
      },
      "kind": "list",
      "text": "$279B in antibody sales by 2025 (up from ~$238B in 2022); 51 blockbuster antibodies in 2022; 5 best-selling antibodies had ~$75B of sales in 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fd27246-9e37-4f16-a277-702f352e2755",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.75,
        "x": 0.04,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Sources: Clarivate Analytics Cortellis database. Tables of approved mAbs and antibodies in review available at: https://www.antibodysociety.org/resources/approved-antibodies/ (1) Defined as composite success rate of clinical development from Phase I trials to Approval, data from 2011-2020. Source: BIO | QLS Advisors | Informa Feb 2021 Report.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e71603c-50e4-4836-8187-442f4e2b1a86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.43,
        "x": 0.04,
        "y": 0.062
      },
      "kind": "table",
      "text": "Type of Drug: Small Molecules (7.5%), Antibodies (12.1%)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f3c2b13-e460-49bc-891a-8b808de284c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.92,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "title",
      "text": "HIGHER CLINICAL SUCCESS RATES FOR ANTIBODY MEDICINES DRIVE OUR INDUSTRY'S NEED FOR DISCOVERY TECHNOLOGY",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0891bd0b-3ed2-4b82-b406-140c095425f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Antibodies and Industry Demand",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "337a2bb1-bdc6-4cf5-a343-fafc5b3f43d2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "0fe17898-8a5d-40aa-9a27-23bf786d400f",
      "evidence": "The slide presents data in a narrative context, telling a story about industry demand and growth.",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "market-sizing",
      "slug": null,
      "matchId": "e070dc8d-4eed-4afa-aa25-3fe88d3301d6",
      "evidence": "Quantifies market growth and success rates to justify industry demand.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 1,
      "beatId": "40bd66a8-aa19-4242-800e-a6baa6acf96e",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Attention",
      "beatSlug": "aida-attention",
      "evidence": "The deck starts with an executive summary, mission, and market sizing to grab the audience's attention.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c9464b73-5d72-4cd7-a643-34a139bcb87a",
      "evidence": "The deck presents the need for discovery technology and the limitations of current solutions.",
      "position": 0,
      "objective": "What are the consequences of not investing in OmniAb's platform?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}